265 related articles for article (PubMed ID: 31479865)
1. Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexone.
Schwienteck KL; Blake S; Bremer PT; Poklis JL; Townsend EA; Negus SS; Banks ML
Drug Alcohol Depend; 2019 Nov; 204():107501. PubMed ID: 31479865
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys.
Bowen CA; Fischer BD; Mello NK; Negus SS
J Pharmacol Exp Ther; 2002 Jul; 302(1):264-73. PubMed ID: 12065726
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a Dual Fentanyl/Heroin Vaccine on the Antinociceptive and Reinforcing Effects of a Fentanyl/Heroin Mixture in Male and Female Rats.
Townsend EA; Bremer PT; Faunce KE; Negus SS; Jaster AM; Robinson HL; Janda KD; Banks ML
ACS Chem Neurosci; 2020 May; 11(9):1300-1310. PubMed ID: 32271538
[TBL] [Abstract][Full Text] [Related]
4. Vaccine blunts fentanyl potency in male rhesus monkeys.
Tenney RD; Blake S; Bremer PT; Zhou B; Hwang CS; Poklis JL; Janda KD; Banks ML
Neuropharmacology; 2019 Nov; 158():107730. PubMed ID: 31369740
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
[TBL] [Abstract][Full Text] [Related]
6. Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and beta-funaltrexamine.
Negus SS; Brandt MR; Gatch MB; Mello NK
Drug Alcohol Depend; 2003 May; 70(1):17-27. PubMed ID: 12681522
[TBL] [Abstract][Full Text] [Related]
7. Conjugate vaccine produces long-lasting attenuation of fentanyl vs. food choice and blocks expression of opioid withdrawal-induced increases in fentanyl choice in rats.
Townsend EA; Blake S; Faunce KE; Hwang CS; Natori Y; Zhou B; Bremer PT; Janda KD; Banks ML
Neuropsychopharmacology; 2019 Sep; 44(10):1681-1689. PubMed ID: 31043682
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone.
Walker JR; King M; Izzo E; Koob GF; Pasternak GW
Eur J Pharmacol; 1999 Oct; 383(2):115-9. PubMed ID: 10585524
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus effects of carfentanil in rats discriminating fentanyl: Differential antagonism by naltrexone.
Flynn SM; France CP
Drug Alcohol Depend; 2021 Apr; 221():108599. PubMed ID: 33631547
[TBL] [Abstract][Full Text] [Related]
10. Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine.
Walker EA; Young AM
J Pharmacol Exp Ther; 2002 Jul; 302(1):101-10. PubMed ID: 12065706
[TBL] [Abstract][Full Text] [Related]
11. Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats.
White DA; Holtzman SG
J Pharmacol Exp Ther; 2001 Jul; 298(1):156-64. PubMed ID: 11408537
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone antagonism of morphine antinociception in sucrose- and chow-fed rats.
D'Anci KE; Kanarek RB
Nutr Neurosci; 2004 Feb; 7(1):57-61. PubMed ID: 15085560
[TBL] [Abstract][Full Text] [Related]
13. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
14. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
Comer SD; Burke TF; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
[TBL] [Abstract][Full Text] [Related]
15. Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice.
Eriksen GS; Andersen JM; Boix F; Bergh MS; Vindenes V; Rice KC; Huestis MA; Mørland J
J Pharmacol Exp Ther; 2016 Aug; 358(2):209-15. PubMed ID: 27278234
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
Zhang L; Walker EA; Sutherland J; Young AM
Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
Narita M; Imai S; Itou Y; Yajima Y; Suzuki T
Life Sci; 2002 Apr; 70(20):2341-54. PubMed ID: 12150199
[TBL] [Abstract][Full Text] [Related]
18. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
[TBL] [Abstract][Full Text] [Related]
19. Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice.
Rady JJ; Gorny JM; Fujimoto JM
Jpn J Pharmacol; 1998 Dec; 78(4):443-54. PubMed ID: 9920201
[TBL] [Abstract][Full Text] [Related]
20. Non-opioid induction of morphine-6-glucuronide synthesis is elicited by prolonged exposure of rat hepatocytes to heroin.
Graziani M; Antonilli L; Togna AR; Brusadin V; Viola S; Togna G; Badiani A; Nencini P
Drug Alcohol Depend; 2008 Dec; 98(3):179-84. PubMed ID: 18597954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
